These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8877102
1. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. David-Pfeuty T, Chakrani F, Ory K, Nouvian-Dooghe Y. Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102 [Abstract] [Full Text] [Related]
2. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. Wesierska-Gadek J, Schmid G. Cell Mol Biol Lett; 2001 Sep; 6(2):117-40. PubMed ID: 11544635 [Abstract] [Full Text] [Related]
3. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA. Oncogene; 1997 May 08; 14(18):2137-47. PubMed ID: 9174049 [Abstract] [Full Text] [Related]
4. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Pollock R, Lang A, Ge T, Sun D, Tan M, Yu D. Clin Cancer Res; 1998 Aug 08; 4(8):1985-94. PubMed ID: 9717829 [Abstract] [Full Text] [Related]
5. Intracellular localization of p53 tumor suppressor protein in gamma-irradiated cells is cell cycle regulated and determined by the nucleus. Komarova EA, Zelnick CR, Chin D, Zeremski M, Gleiberman AS, Bacus SS, Gudkov AV. Cancer Res; 1997 Dec 01; 57(23):5217-20. PubMed ID: 9393737 [Abstract] [Full Text] [Related]
6. Retrovirally mediated wild-type p53 restores S-phase modulation without inducing WAF1 mRNA in breast carcinoma cells containing mutant p53. Runnebaum IB, Wang S, Kreienberg R. J Cell Biochem; 1995 Dec 01; 59(4):537-44. PubMed ID: 8749722 [Abstract] [Full Text] [Related]
7. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Moretti F, Farsetti A, Soddu S, Misiti S, Crescenzi M, Filetti S, Andreoli M, Sacchi A, Pontecorvi A. Oncogene; 1997 Feb 13; 14(6):729-40. PubMed ID: 9038381 [Abstract] [Full Text] [Related]
8. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity. Galmarini CM, Falette N, Tabone E, Levrat C, Britten R, Voorzanger-Rousselot N, Roesch-Gateau O, Vanier-Viornery A, Puisieux A, Dumontet C. Br J Cancer; 2001 Sep 14; 85(6):902-8. PubMed ID: 11556844 [Abstract] [Full Text] [Related]
9. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression. Steinmeyer K, Maacke H, Deppert W. Oncogene; 1990 Nov 14; 5(11):1691-9. PubMed ID: 2267135 [Abstract] [Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar 14; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
11. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53. Olivier M, Bautista S, Vallès H, Theillet C. Mol Carcinog; 1998 Sep 14; 23(1):1-12. PubMed ID: 9766432 [Abstract] [Full Text] [Related]
12. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells. Lilling G, Elena N, Sidi Y, Bakhanashvili M. Oncogene; 2003 Jan 16; 22(2):233-45. PubMed ID: 12527892 [Abstract] [Full Text] [Related]
13. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein. Dkhissi F, Raynal S, Jullien P, Lawrence DA. Oncogene; 1999 Jan 21; 18(3):703-11. PubMed ID: 9989820 [Abstract] [Full Text] [Related]
15. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation. Pocard M, Chevillard S, Villaudy J, Poupon MF, Dutrillaux B, Remvikos Y. Oncogene; 1996 Feb 15; 12(4):875-82. PubMed ID: 8632910 [Abstract] [Full Text] [Related]
16. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Xu D, Wang Q, Gruber A, Björkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG, Pisa P. Oncogene; 2000 Oct 26; 19(45):5123-33. PubMed ID: 11064449 [Abstract] [Full Text] [Related]
17. Levels of p53 in Epstein-Barr virus-infected cells determine cell fate: apoptosis, cell cycle arrest at the G1/S boundary without apoptosis, cell cycle arrest at the G2/M boundary without apoptosis, or unrestricted proliferation. Chen W, Huang S, Cooper NR. Virology; 1998 Nov 25; 251(2):217-26. PubMed ID: 9837785 [Abstract] [Full Text] [Related]
18. Polyomavirus large T antigen overcomes p53 dependent growth arrest. Doherty J, Freund R. Oncogene; 1997 Apr 24; 14(16):1923-31. PubMed ID: 9150359 [Abstract] [Full Text] [Related]
19. Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection. Nagasawa H, Keng P, Maki C, Yu Y, Little JB. Cancer Res; 1998 May 01; 58(9):2036-41. PubMed ID: 9581850 [Abstract] [Full Text] [Related]
20. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. Ling YH, Zou Y, Perez-Soler R. Anticancer Res; 2000 May 01; 20(2A):693-702. PubMed ID: 10810342 [Abstract] [Full Text] [Related] Page: [Next] [New Search]